Cardiopulmonary Disease Diagnostics Treatment Companies
There are numerous companies dedicated to the diagnostics and treatment of cardiopulmonary diseases, leveraging advanced technologies and innovative approaches to improve patient outcomes.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Â
Latest Cardiopulmonary Disease Diagnostics and Treatment Companies Updates:
Philips: Introduced the Lumify L15 portable ultrasound system, designed for point-of-care assessment of cardiovascular and respiratory functions, increasing accessibility and early diagnosis.
Abbott: Received FDA approval for the Amplatzer™ Amulet™ Septal Occluder for percutaneous closure of patent foramen ovale (PFO), a potential contributor to stroke, offering a minimally invasive treatment option.
Roche Diagnostics: Developed new blood tests for detecting early-stage heart failure and predicting risk of pulmonary embolism, enabling earlier intervention and improved patient outcomes.
Siemens Healthineers: Acquired Varian Medical Systems, expanding its portfolio of oncology and cardiovascular imaging solutions and strengthening its presence in the healthcare technology landscape.
Johnson & Johnson: Partnered with Verily Life Sciences to develop AI-powered algorithms for diagnosing and managing heart failure, aiming to improve patient outcomes and reduce hospital readmissions.
Novartis: Collaborated with academic institutions and data science companies to develop machine learning models for predicting and preventing acute respiratory distress syndrome (ARDS), a potentially life-threatening complication of various illnesses.
List of Cardiopulmonary Disease Diagnostics and Treatment Key companies in the market:
- Cardinal Health
- Cosmed Medical
- GE Healthcare
- Halma plc
- Hill-Rom Holdings Inc.
- Koninklijke Philips N.V.
- MGC Diagnostics Corporation
- NIHON KOHDEN CORPORATION
- Schiller AG
- Masimo Corporation
Cardiopulmonary Disease Diagnostics Treatment Market Highlights:
Cardiopulmonary Disease Diagnostics Treatment Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
